MCM2 is an independent predictor of survival in patients with non-small-cell lung cancer.
暂无分享，去创建一个
G. Bepler | I. Todorov | J. Huberman | N. Natarajan | N. Ramnath | J. Brooks | A. Beck | A. Hyland | D. Tan | F. Hernandez | Dongfeng Tan | Nithya Ramnath | Francisco J. Hernandez | Nachimuthu Natarajan | Amy Beck | Andrew Hyland | Ivan T. Todorov | John S. J. Brooks